Hydroquinidine Modulates Histopathological, Inflammatory, Apoptotic, EMT-Related, and PI3K/AKT/mTOR-Associated Markers in a DMH-Induced Rat Model of Colon Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27135672 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von İlknur Keskin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Histology and Embryology Department, School of Medicine, İstanbul Medipol University, İstanbul 34810, Turkey. Hauptthemen laut MEDLINE: Apoptosis, Epithelial-Mesenchymal Transition, Colonic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Sağlık Enstitüleri Başkanlığı, Health Institutes of Türkiye.
Abstract (Originalsprache)
Colon cancer remains a leading cause of cancer-related deaths, and drug repurposing offers a promising strategy to identify new therapies. Hydroquinidine (HQ), a class I antiarrhythmic agent, has recently been suggested to possess anticancer properties; however, its preclinical safety and efficacy in colorectal cancer are not well defined. The safety of HQ was evaluated in Wistar rats following OECD guidelines. Rats received daily intraperitoneal doses (2.5–25 mg/kg) for 90 days, with hematological, biochemical, and histopathological assessments performed. HQ was well tolerated up to 12.5 mg/kg, whereas 25 mg/kg caused signs of hepatotoxicity without lethality. A 1,2-dimethylhydrazine-induced colorectal cancer model was then used to assess HQ at safe doses (6.25 and 12.5 mg/kg) compared with cisplatin. Tissue histopathology and selected molecular markers associated with inflammation, apoptosis, epithelial–mesenchymal transition, and PI3K/AKT/mTOR pathway activity were analyzed. In the DMH-induced colon cancer model, HQ improved colonic tissue architecture and was associated with lower histopathological scores compared with untreated tumor controls. HQ also modulated tumor-associated markers by reducing IL-6 immunoreactivity, increasing caspase-3 expression, enhancing E-cadherin immunoreactivity, and decreasing vimentin expression. Moreover, HQ was associated with reduced immunoreactivity of mTOR pathway-related markers, suggesting attenuation of pathway activation in this experimental context. Overall, HQ showed an acceptable safety profile at the selected doses and exerted favorable histopathological and molecular modulatory effects, supporting further investigation as a potential repurposing candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Histology and Embryology Department, School of Medicine, İstanbul Medipol University, İstanbul 34810, Turkey.
- Program of Histology and Embryology, Institute of Health Sciences, İstanbul Medipol University, İstanbul 34810, Turkey.
- Department of Physiology, Faculty of Milas Veterinary Medicine, Muğla Sıtkı Kocman University, Muğla 48200, Turkey.
- Veterinary Physiology Program, Institute of Health Sciences, Muğla Sıtkı Kocman University, Muğla 48200, Turkey.
- Molecular Biology and Genetics Program, Institute of Natural Sciences, Muğla Sıtkı Kocman University, Muğla 48000, Turkey.
- Histology and Embryology Department, School of Medicine, Ağrı İbrahim Çeçen University, Ağrı 04000, Turkey.
ORCID-Profile: Muhammet Volkan Bülbül
Förderung
- Türkiye Sağlık Enstitüleri Başkanlığı
- Health Institutes of Türkiye
Zitieren
APA
Keskin, İ., Şahin, B., Bülbül, A., Çakır, M., Yavuz, M., Bülbül, M. V., & Demircan, T. (2026). Hydroquinidine Modulates Histopathological, Inflammatory, Apoptotic, EMT-Related, and PI3K/AKT/mTOR-Associated Markers in a DMH-Induced Rat Model of Colon Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27135672
Vancouver
Keskin İ, Şahin B, Bülbül A, Çakır M, Yavuz M, Bülbül MV, et al. Hydroquinidine Modulates Histopathological, Inflammatory, Apoptotic, EMT-Related, and PI3K/AKT/mTOR-Associated Markers in a DMH-Induced Rat Model of Colon Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27135672
BibTeX
@article{Keskin2026,
author = {Keskin, İlknur and Şahin, Begüm and Bülbül, Aziz and Çakır, Mustafa and Yavuz, Mervenur and Bülbül, Muhammet Volkan and Demircan, Turan},
title = {Hydroquinidine Modulates Histopathological, Inflammatory, Apoptotic, EMT-Related, and PI3K/AKT/mTOR-Associated Markers in a DMH-Induced Rat Model of Colon Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27135672}
}
EUVIMED